You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Intraepithelial T Cells

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Squamous Lntraepithelial Lesions of Vulva, Tumors, Squamous Cell, Vulvar HSIL Trial run by the NCI (E7 T Cell Receptor (TCR))

Terminated
Has Results
  • Squamous Lntraepithelial Lesions of Vulva
  • +2 more
  • E7 T Cell Receptor (TCR)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Mar 18, 2021

Human Papillomavirus, HPV-16, High Grade Squamous Intraepithelial Lesion Trial run by the NCI (Aldesleukin, E6 T Cell Receptor

Terminated
Has Results
  • Human Papillomavirus
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 1, 2021

Primary Cervical Cancer Screening by Self-sampling HPV Test

Recruiting
  • Human Papillomavirus Infection
  • +16 more
    • Beijing, Beijing, China
    • +5 more
    Jan 12, 2023

    Multiple Myeloma Trial (BCMA-TGFß CAR-T cells (0.75 x10^6 cells/kg), BCMA-TGFß CAR-T cells (1 x 10^6 cells/kg), BCMA-TGFß CAR-T

    Not yet recruiting
    • Multiple Myeloma
    • BCMA-TGFβ CAR-T cells (0.75 x10^6 cells/kg)
    • +3 more
    • (no location specified)
    Jul 28, 2023

    Pancreatic Cancer Trial in ShangHai (TCR-T Cells Injection(GB3010 Cells Injection))

    Recruiting
    • Pancreatic Cancer
    • TCR-T Cells Injection（GB3010 Cells Injection）
    • ShangHai, Shanghai, China
      Ruijin Hospital Affiliated to Shanghai Jiaotong University Schoo
    Sep 19, 2023

    Relapse/Refractory Multiple Myeloma Trial in Hangzhou (DeepTag-GPRC5D Targeted CAR T-cells)

    Recruiting
    • Relapse/Refractory Multiple Myeloma
    • DeepTag-GPRC5D Targeted CAR T-cells
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Oct 10, 2023

    Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,

    Not yet recruiting
    • Prostate Carcinoma
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 17, 2023

    Multiple Myeloma in Remission Trial in Shenzhen, Haikou (MM-specific universal CAR T cells)

    Recruiting
    • Multiple Myeloma in Remission
    • MM-specific universal CAR T cells
    • Shenzhen, Guangdong, China
    • +1 more
    Aug 23, 2023

    Metastatic Colorectal Adenocarcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

    Not yet recruiting
    • Metastatic Colorectal Adenocarcinoma
    • +5 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Sep 12, 2023

    Relapsed Acute Myeloid Leukaemia Trial (Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL))

    Not yet recruiting
    • Relapsed Acute Myeloid Leukaemia
    • Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL)
    • (no location specified)
    Jul 4, 2023

    Clinical Evaluation of Detection of High Risk HPV in Urine

    Recruiting
    • Human Papillomavirus Infection
    • +17 more
      • Beijing, Beijing, China
      • +2 more
      Jan 21, 2022

      T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial (CD7-CART01)

      Not yet recruiting
      • T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
      • CD7-CART01
      • (no location specified)
      Sep 26, 2023

      TINO: T Cells in the Nose of Older Adults

      Recruiting
      • Respiratory Tract Infections
      • Aging
        • Leiden, Zuid Holland, Netherlands
          Leiden University Medical Center
        Sep 8, 2023

        EBV Infection After Allogenic HSCT Trial in Beijing (EBV-TCR-T cells)

        Recruiting
        • EBV Infection After Allogenic HSCT
        • EBV-TCR-T cells
        • Beijing, Beijing, China
          Chinese PLA General Hospital
        Nov 3, 2023

        Diffuse Large B-cell Lymphoma Trial in Hangzhou (Metabolically Armed CD19 CAR-T cells)

        Recruiting
        • Diffuse Large B-cell Lymphoma
        • Metabolically Armed CD19 CAR-T cells
        • Hangzhou, Zhejiang, China
          The first affiliated hospital of medical college of zhejiang uni
        Nov 1, 2023

        Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Duarte

        Not yet recruiting
        • Castration-Resistant Prostate Carcinoma
        • +2 more
        • Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes
        • +7 more
        • Duarte, California
          City of Hope Medical Center
        Apr 5, 2023

        Advanced Solid Tumor Trial in Beijing (aPD1-MSLN-CAR T Cells)

        Not yet recruiting
        • Advanced Solid Tumor
        • αPD1-MSLN-CAR T Cells
        • Beijing, China
          National Cancer Center Cancer Hospital Chinese Academy of Medica
        Jul 13, 2023

        Glioblastoma, Malignant Glioma, Recurrent Glioblastoma Trial in Boston (CARv3-TEAM-E T cells)

        Not yet recruiting
        • Glioblastoma
        • +3 more
        • CARv3-TEAM-E T cells
        • Boston, Massachusetts
          Massachusetts General Hospital Cancer Center
        Dec 13, 2022

        Acute Myeloid Leukemia, Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Anti-CD33 CAR

        Not yet recruiting
        • Acute Myeloid Leukemia
        • +3 more
        • Anti-CD33 CAR T-cells
        • Lymphodepletion Therapy
        • Duarte, California
          City of Hope Medical Center
        Jan 3, 2023

        Non-hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Boston (CD79b-19 CAR T cells,

        Not yet recruiting
        • Non-hodgkin Lymphoma
        • +9 more
        • CD79b-19 CAR T cells
        • +2 more
        • Boston, Massachusetts
          Massachusetts General Hospital
        Sep 6, 2023

        EBV-associated Hemophagocytic Lymphohistiocytosis, EBV Infection Trial in Beijing (EBV-TCR-T cells)

        Recruiting
        • EBV-associated Hemophagocytic Lymphohistiocytosis
        • EBV Infection
        • EBV-TCR-T cells
        • Beijing, Beijing, China
          Chinese PLA General Hospital
        Nov 12, 2023

        Multiple Myeloma, Immune System Diseases Trial in Chapel Hill (CAR138 T Cells)

        Recruiting
        • Multiple Myeloma
        • Immune System Diseases
        • CAR138 T Cells
        • Chapel Hill, North Carolina
          Lineberger Comprehensive Cancer Center at University of North Ca
        Jan 10, 2023

        Multiple Myeloma Trial in Wuhan (Fludarabine + Cyclophosphamide + BCMA-GPRC5D CAR-T Cells)

        Recruiting
        • Multiple Myeloma
        • Fludarabine + Cyclophosphamide + BCMA-GPRC5D CAR-T Cells
        • Wuhan, Hubei, China
          Union Hospital, Tongji Medical College, Huazhong University of S
        Aug 11, 2023

        T-bet B Cells in Persistent Virus Control After Discontinuance

        Completed
        • Chronic HBV Infection
        • Drug Withdrawal
        • T-bet B cell
        • Shanghai, China
          Changhai hospital
        Sep 1, 2023

        Acute Myeloid Leukemia Trial in Beijing, Shenzhen, Haikou (CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T cells)

        Recruiting
        • Acute Myeloid Leukemia
        • CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T cells
        • Beijing, Beijing, China
        • +2 more
        Aug 8, 2023